Basing on these data, the rationale for HSP90 as a potential targetable molecule may offer interesting alternative therapeutic options for gastrointestinal tumors, especially for Her2 positive gastric and esophageal adenocarcinomas [29,35]. The gene discussed is ERBB2; the disease is digestive system neoplasm.